Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma (vol 9, pg 546, 2019)

科研成果详情

名称	Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma (vol 9, pg 546, 2019)
作者	Ding, Xiwei 1; Zhang, Yiyang 2; Huang, Tianlu 1; Xu, Guifang 1; Peng, Chunyan 1; Chen, Gang3; Kong, Bo 1,4; Friess, Helmut 4; Shen, Shanshan 1; Lv, Ying 1; Roberts, Lewis R.5,6; Wang, Lei 1; Zou, Xiaoping 2
发表期刊	AMERICAN JOURNAL OF CANCER RESEARCH
语种	英语
原始文献类型	Correction
出版者	E-CENTURY PUBLISHING CORP
ISSN	2156-6976
期号	11
页码	5684-5685
页数	2
WOS类目	Oncology
WOS研究方向	Oncology
WOS记录号	WOS:001122825000021
收录类别	SCIE
发布日期	2023
通讯作者地址	[Zou, Xiaoping]Nanjing Med Univ, Nanjing Drum Tower Hosp, Dept Gastroenterol, Clin Coll, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.
引用统计
文献类型	其他
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/213220
专题	附属第一医院_肝胆外科
通讯作者	Zou, Xiaoping
作者单位	1.Nanjing Univ, Med Sch, Affiliated Hosp, Dept Gastroenterol,Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; 2.Nanjing Med Univ, Nanjing Drum Tower Hosp, Dept Gastroenterol, Clin Coll, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China; 3.Wenzhou Med Univ, Affiliated Hosp 1, Div Hepatobiliary Surg, Wenzhou 325000, Zhejiang, Peoples R China; 4.Tech Univ Munich, Dept Surg, D-80333 Munich, Germany; 5.Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; 6.Mayo Clin, Canc Ctr, Rochester, MN 55905 USA
推荐引用方式 GB/T 7714	Ding, Xiwei,Zhang, Yiyang,Huang, Tianlu,et al. Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma (vol 9, pg 546, 2019). 2023.